AIVITA Biomedical Receives $1.7 million in Funding as Part of UCI Awarded CIRM Grant to Treat Vision Loss
AIVITA Biomedical CEO Dr. Hans Keirstead to Moderate Keynote Panel of Pharma Industry Leaders at World Vaccine Congress EU>
AIVITA Biomedical CEO Dr. Hans Keirstead to Participate in Keynote Panel and Deliver Talk at Festival of Biologics Europe
AIVITA Biomedical CEO Dr. Hans Keirstead to Moderate Keynote Panel of Pharma Industry Leaders at World Vaccine Congress EU>
AIVITA Biomedical CEO Dr. Hans Keirstead to Participate in Keynote Panel and Deliver Talk at Festival of Biologics Europe